An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
المؤلف الرئيسي: | Bristy, Israt Zerin |
---|---|
مؤلفون آخرون: | Kabir, Md. Tanvir |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
Brac University
2021
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://hdl.handle.net/10361/15619 |
مواد مشابهة
-
Molecules associated with the development of lung cancer
بواسطة: Rahman, Adree, وآخرون
منشور في: (2023) -
A case study of lung cancer patients in term of various risk factors in context of Bangladesh
بواسطة: Shabnam, Musharrat
منشور في: (2018) -
Immunotherapy in the Management of Lung Cancer
بواسطة: Tasnim, Humayra
منشور في: (2022) -
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
بواسطة: Paul, Pulock
منشور في: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
بواسطة: Mim, Shanzida
منشور في: (2023)